Medical Licensing (MD/DO) · Independent exam preparation
MRCP(UK) Part 1: Clinical Reasoning and Applied Sciences Study Guide
Practise interpreting clinical clues, mechanisms and investigations across all 17 MRCP(UK) Part 1 domains, with 60 focused concepts and explained question drills.
By CertMedbry · Updated 27 October 2026
Interpret investigation results, distinguish close clinical alternatives and connect mechanisms to decisions at entry to specialist physician training. This selective guide develops 60 concepts across all 17 official domains. The Federation's complete Part 1 outline defines the full examination scope; these selected topics do not exhaust it. Use the explanations, cases and independent question drills to identify reasoning gaps and direct broader study.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and qualification does this guide address?
The MRCP(UK) Part 1 Examination, organised through the Federation's MRCP(UK) division on behalf of the three participating UK Royal Colleges. Part 1 assesses clinical sciences and important disorders at entry to specialist training. Part 2 Written and Part 2 Clinical, known as PACES, are separate components of the diploma.
How many papers and questions are in Part 1, and are pretest questions identified?
As checked on 26 October 2026, Part 1 has two papers, each containing 100 best-of-five questions and lasting three hours: 200 questions overall. A separate scored-versus-pretest breakdown is not confirmed here; candidates should not assume a particular number of unscored questions.
What question style should candidates expect?
The written examinations use best-of-five questions: candidates choose one best answer from five options. Each correct answer earns one mark, with no negative marking. This guide contains 20 independent four-option learning questions. They practise reasoning but do not reproduce the examination's option count or constitute a complete mock examination.
Part 1: Format — The Federation · Regulations for MRCP(UK) Examination Candidates
How is the examination delivered, and is it adaptive?
The September 2026 regulations specify in-centre computer-based delivery from June 2026, with agreed exceptions described in the regulations. Computer-based delivery alone does not establish adaptive testing, and an adaptive format is not confirmed here. Follow the official arrangements and booking instructions for your sitting.
Regulations for MRCP(UK) Examination Candidates · Regulations — The Federation
How long is the examination, and what is the pass mark?
As checked on 26 October 2026, each of the two papers lasts three hours. From the 2026/1 examination diet, the pass mark is an overall scaled score of 450. This is not a fixed percentage correct: equating accounts for differences in examination difficulty. See the Federation's [pass-mark explanation](https://www.thefederation.uk/examinations/guidance-and-information/pass-marks-explained).
Which blueprint and regulations apply?
The published Part 1 blueprint states applicability from the 2020/1 examination diet and remained published when checked on 10 October 2026. This does not establish a separate 2026 blueprint revision. The accompanying examination regulations are version 2.2, September 2026, applying from publication.
Part 1: Format — The Federation · Regulations for MRCP(UK) Examination Candidates
How are questions distributed across the official domains?
Indicative allocations out of 200 are: Clinical sciences 25; Clinical Pharmacology and Therapeutics 15; Cardiology, Endocrinology, diabetes and metabolic medicine, Gastroenterology and Hepatology, Infectious diseases, Neurology, Renal medicine, Respiratory medicine and Rheumatology 14 each; Haematology 10; Psychiatry 9; Dermatology and Geriatric medicine 8 each; Oncology 5; Medical ophthalmology and Palliative medicine and end of life care 4 each. Actual allocations may vary slightly.
How should this selective guide be used alongside the full outline?
Use the official outline as the full scope. Its Clinical sciences allocation includes cell, molecular and membrane biology; clinical anatomy; clinical biochemistry and metabolism; clinical physiology; genetics; immunology; and statistics, epidemiology and evidence-based medicine. This guide approximates the domain emphasis while ensuring every domain appears. A 20-question or 20-card set cannot reproduce every official proportion.
MRCP(UK) Part 1 is a postgraduate written component of the MRCP(UK) Diploma, which also includes Part 2 Written and PACES. It is not a standalone medical licensing qualification. This independently authored guide follows the Part 1 pathway and provides original educational exercises.
Outline used: Official Part 1 blueprint effective from the 2020/1 examination diet, still published on the current Federation format page when checked on 2026-10-10. Accompanying MRCP(UK) Examination Regulations: version 2.2, September 2026. The workbook label maps to the official MRCP(UK) Part 1 Examination; the assigned canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Cardiology7% (14/200; indicative)
1.How is suspected atrial fibrillation confirmed?
An irregular pulse raises suspicion of atrial fibrillation, but an electrocardiogram establishes the rhythm diagnosis. Disorganised atrial electrical activity produces an irregular ventricular response rather than coordinated atrial contraction. Palpitations, breathlessness and fatigue can prompt investigation, although some people have no symptoms. The useful decision is to distinguish a screening clue from rhythm confirmation before attributing symptoms or planning treatment.
Apply it
A 72-year-old reports intermittent palpitations, and examination finds an irregular pulse. Obtain an ECG to identify the rhythm; the pulse finding alone does not establish which arrhythmia is responsible for the symptoms.
Common pitfall: Calling every irregular pulse atrial fibrillation bypasses rhythm confirmation. Symptoms and pulse examination suggest the diagnosis but do not establish its electrical basis.
2.Why must symptom control and stroke prevention be assessed separately in atrial fibrillation?
Disrupted atrial contraction permits blood stasis and clot formation; embolisation can obstruct a cerebral artery. Rate control slows the ventricular response, whereas rhythm control aims to restore or maintain sinus rhythm. These approaches address symptoms and electrical function, but symptomatic improvement alone does not establish that thromboembolic risk has been addressed. Atrial fibrillation can also be asymptomatic, so absence of palpitations is not evidence of protection from stroke.
Apply it
A patient feels better after ventricular rate control but remains in atrial fibrillation. Explain that a slower pulse can improve symptoms while the need for stroke prevention still requires separate assessment.
Common pitfall: Equating a comfortable, slower pulse with removal of embolic risk confuses treatment objectives. Neither symptom intensity nor an apparent rhythm improvement alone settles the prevention decision.
3.When should breathlessness attributed to COPD prompt investigation for cardiac disease?
COPD and cardiac disease can coexist. Breathlessness accompanied by oedema, tachycardia, cardiovascular history or suspected pulmonary hypertension warrants cardiac assessment rather than automatic escalation of respiratory treatment. ECG and serum natriuretic peptides assess relevant cardiac abnormalities; echocardiography evaluates cardiac structure and function. These investigations answer a different question from spirometry: whether cardiac disease contributes to symptoms that may appear respiratory.
Apply it
A patient with established COPD develops ankle oedema and breathlessness disproportionate to the measured airflow limitation. Investigate a cardiac contribution with ECG, natriuretic peptides and echocardiography as indicated.
Common pitfall: An established pulmonary diagnosis does not explain every subsequent episode of breathlessness. Spirometry cannot replace investigation of suspected heart failure or other cardiac disease.
4.Which combination should raise suspicion of infective endocarditis?
Persistent fever, night sweats or unexplained weight loss in someone with an artificial valve, valve disease, an intracardiac device or previous endocarditis should raise concern for infection of the heart's inner lining. Organisms can reach the heart through the bloodstream. Blood testing investigates infection, while echocardiography assesses cardiac involvement and damage. The [NHS endocarditis overview](https://www.nhs.uk/conditions/endocarditis/) describes these risk factors and investigations.
Apply it
A patient with an artificial valve develops several weeks of fever, night sweats and worsening breathlessness. Arrange urgent assessment for possible endocarditis rather than attributing the symptoms solely to a minor intercurrent illness.
Common pitfall: Endocarditis can evolve gradually over weeks or months. An absence of dramatic acute collapse does not exclude a serious infection in a patient with a relevant cardiac risk factor.
Clinical Pharmacology and Therapeutics7.5% (15/200; indicative)
5.Which molecular target explains warfarin's anticoagulant effect?
Warfarin inhibits vitamin K epoxide reductase, reducing regeneration of the active vitamin K needed to produce functional vitamin K-dependent clotting proteins. The affected coagulation factors include II, VII, IX and X; proteins C and S are also vitamin K dependent. Warfarin therefore alters synthesis of functional proteins rather than directly neutralising circulating thrombin. This mechanism explains both its delayed effect and the need for laboratory monitoring.
Apply it
A patient asks whether a first warfarin tablet immediately blocks thrombin already circulating in the blood. Explain that it interferes with vitamin K recycling and the production of functional clotting proteins, so its effect develops over time.
Common pitfall: Calling warfarin a direct thrombin inhibitor confuses two drug mechanisms. Its main target is vitamin K recycling, not the active site of thrombin.
6.Why is warfarin's full effect delayed?
Warfarin reduces the production of functional vitamin K-dependent clotting factors, but factors already circulating remain active until they are cleared. Different proteins disappear at different rates, so an early laboratory change does not mean every relevant factor has fallen equally. The pharmacodynamic response therefore lags behind drug administration. When interpreting initiation, distinguish drug exposure, an evolving INR response and the eventual reduction in the full set of affected factors.
Apply it
An INR changes soon after warfarin initiation, and a learner assumes that all vitamin K-dependent factors are already equally depleted. Explain that differing protein turnover makes the early response an incomplete picture of the eventual anticoagulant effect.
Common pitfall: Assuming that an early INR response proves immediate maximal anticoagulation ignores the persistence of existing clotting factors and their differing elimination rates.
7.When should lithium toxicity be suspected?
Lithium toxicity can produce gastrointestinal disturbance and neurological findings such as coarse tremor, ataxia, confusion or impaired coordination. Clinical toxicity can occur even when a measured concentration is not clearly above the laboratory range. When toxicity is suspected, withhold lithium, obtain an urgent lithium concentration and renal function with electrolytes, and seek specialist advice. The decision depends on the clinical picture as well as the numerical result.
Apply it
A patient taking lithium develops vomiting, a coarse tremor and an unsteady gait during an intercurrent illness. Withhold lithium and arrange urgent lithium, electrolyte and renal assessment rather than waiting for the next scheduled monitoring appointment.
Common pitfall: A previously satisfactory lithium concentration does not exclude current toxicity. Illness and renal changes can alter exposure after the last routine blood test.
8.Which measurements make lithium monitoring clinically useful?
Lithium monitoring combines a correctly timed serum concentration with assessment of renal function, thyroid function and calcium. A concentration is usually interpreted as a trough sample taken 12 hours after the preceding dose. Sampling time matters because a result obtained soon after a dose is not comparable with a trough target. Renal, thyroid and calcium measurements identify important effects that a lithium concentration alone cannot reveal.
Apply it
A stable patient has a lithium sample collected two hours after the morning dose, and the result appears high. Check the collection timing before comparing it with a trough range, while also reviewing symptoms and the wider monitoring results.
Common pitfall: Treating every lithium sample as an equivalent trough can lead to inappropriate interpretation. A concentration also cannot replace renal, thyroid or calcium surveillance.
9.Why do fluid and sodium changes matter during lithium treatment?
Lithium exposure is sensitive to renal handling and changes in fluid or sodium balance. Dehydration, substantial dietary sodium changes and medicines that affect renal function can increase the risk of an unsafe concentration. Patients should maintain a consistent fluid and sodium intake and obtain advice during significant illness. A new illness or interacting medicine is therefore a reason to reassess monitoring needs, even after a long stable period.
Apply it
A patient established on lithium develops diarrhoea and markedly reduces oral intake. Review hydration, symptoms and the need for additional testing; stability before the illness does not guarantee an unchanged concentration during the new fluid disturbance.
Common pitfall: Advising abrupt sodium restriction without considering lithium handling can destabilise treatment. Routine monitoring intervals may also be inadequate after an important clinical change.
Clinical sciences12.5% (25/200; indicative)
10.How does a membrane receptor defect cause myasthenic weakness?
In common autoimmune myasthenia gravis, antibodies interfere with acetylcholine receptor function at the postsynaptic neuromuscular membrane. Transmission becomes less reliable, especially with repeated activity, so a muscle that initially contracts adequately may become weak during continued use. This links a molecular and membrane abnormality to fatigability. Fluctuating ptosis, diplopia or chewing weakness is therefore more informative than a general statement that a patient feels tired.
Apply it
A patient can initially keep both eyelids elevated, but one droops during sustained upward gaze and improves after rest. Connect the activity-dependent weakness to impaired neuromuscular transmission rather than simply labelling the symptom as general fatigue.
Common pitfall: Fatigue is a subjective experience with many causes. Myasthenic fatigability is declining muscle performance with use, often involving identifiable ocular or bulbar muscles.
Myasthenia gravis — NHS · Myasthenia Gravis – Overview | Research
11.Which anatomical separation defines retinal detachment?
Retinal detachment is separation of the neurosensory retina from the retinal pigment epithelium. Posterior vitreous detachment instead involves vitreous separation from the retinal surface, as described by the [National Eye Institute](https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/vitreous-detachment). Retinoschisis means splitting within retinal tissue rather than separation from the pigment epithelium; [MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/x-linked-juvenile-retinoschisis/) illustrates this in juvenile retinoschisis. The location of the tissue plane distinguishes these processes.
Apply it
An anatomical description states that neural retinal tissue has lifted away from the pigment epithelium. Identify retinal detachment. A description of vitreous pulling away from the retinal surface identifies a different interface.
Common pitfall: Shared symptoms do not imply identical anatomy. Vitreous detachment can cause retinal tears and subsequent retinal detachment, so new flashes or floaters still require prompt examination.
MeSH Browser · Retinal Detachment — National Eye Institute · Vitreous Detachment | National Eye Institute · X-linked juvenile retinoschisis: MedlinePlus Genetics
12.Why does rapid tumour breakdown raise uric acid?
Rapid tumour cell breakdown releases intracellular material, including nucleic acids whose purines are metabolised to uric acid. Potassium and phosphate are also released, while calcium may fall as phosphate rises. The resulting biochemical load can exceed renal excretory capacity and contribute to kidney injury. This mechanism explains why a treatment response can create an emergency: rapid destruction of malignant cells can be dangerous even when anticancer therapy is working.
Apply it
After treatment for a rapidly proliferating malignancy, a patient develops increasing uric acid, potassium and phosphate. Link these changes to cell breakdown and assess tumour lysis risk rather than interpreting each abnormal result as an unrelated problem.
Common pitfall: Assuming that tumour response can only improve physiology misses the metabolic burden of rapid cell destruction. The biochemical pattern is more informative than urate alone.
Prevention of tumour lysis syndrome — eviQ, Cancer Institute NSW
13.Why does excessive intestinal iron absorption cause progressive tissue overload?
Body iron balance depends heavily on regulation of absorption because humans cannot substantially increase iron excretion to compensate for excess uptake. In hereditary haemochromatosis, excessive absorption therefore produces cumulative tissue storage and damage. This differs from a freely excreted dietary excess. Continuing an ordinary intake can still increase body stores when absorption is inappropriately high.
Apply it
A patient with haemochromatosis asks why iron accumulates despite taking no iron supplements. Explain that excessive absorption from ordinary food can exceed the body's limited capacity to lose iron.
Common pitfall: Assuming the kidneys can simply excrete additional iron overlooks the central role of regulated absorption in iron homeostasis.
14.How does haemochromatosis subtype change inheritance counselling?
Hereditary haemochromatosis is genetically heterogeneous. HFE-, HJV-, HAMP- and TFR2-related forms usually follow autosomal recessive inheritance, whereas SLC40A1-related disease follows autosomal dominant inheritance. The broad disease name therefore does not identify a single family recurrence pattern. Establish the implicated gene before applying a Mendelian risk calculation, and distinguish inheritance of a susceptibility genotype from certainty about the eventual severity of iron-related organ disease.
Apply it
A family asks whether every form of hereditary haemochromatosis gives the same risk to children. Explain that the answer depends on the gene: SLC40A1-related disease has a different inheritance pattern from the common HFE-related form.
Common pitfall: Applying a recessive recurrence calculation to every haemochromatosis subtype ignores genetic heterogeneity. The molecular diagnosis must come before a subtype-specific family risk calculation.
15.Why does hepatitis B vaccination produce a different antibody pattern from infection?
Hepatitis B vaccination exposes the immune system to surface antigen and can produce protective anti-HBs without anti-HBc. Natural infection exposes the immune system to additional viral components, so resolved infection commonly leaves both anti-HBs and total anti-HBc. Antibodies are therefore evidence of exposure to particular antigens, not interchangeable markers of immunity. Reading the antigen targets explains why surface antibody alone and surface-plus-core antibodies have different interpretations.
Apply it
Two people are HBsAg negative and anti-HBs positive. Only one has total anti-HBc. Explain that core antibody supports previous natural infection, whereas surface antibody without core antibody is compatible with vaccine-induced immunity in the appropriate history.
Common pitfall: Calling every anti-HBs-positive result previous infection ignores the antigen specificity of the immune response. Vaccination does not ordinarily produce antibody to hepatitis B core antigen.
16.How is a risk ratio calculated and interpreted?
A risk ratio divides the risk in one group by the risk in a comparison group over a defined period. A value of one indicates equal observed risks; a value below one indicates a lower risk in the numerator group. The result expresses proportional difference, not the number of events prevented. Always identify the numerator, denominator, outcome and follow-up period before interpreting the direction or magnitude of the association.
Apply it
Over one year, an event occurs in 10 of 100 treated participants and 20 of 100 controls. The treated-to-control risk ratio is 0.10 divided by 0.20, or 0.5, indicating half the observed risk.
Common pitfall: Reversing the groups reverses the ratio. A risk ratio also does not show the absolute event difference without the underlying risks being known.
17.Why distinguish absolute from relative risk reduction?
Absolute risk reduction subtracts treated risk from control risk, whereas relative risk reduction expresses that difference as a proportion of control risk. A fall from 20% to 10% is a 10-percentage-point absolute reduction and a 50% relative reduction. These statements describe the same data but answer different questions. Absolute effects help communicate how many events change in a population; relative effects describe the proportional change from baseline risk.
Apply it
Treatment reduces a one-year event risk from 4% to 2%. Report a two-percentage-point absolute reduction and a 50% relative reduction, making clear that the same proportional benefit can correspond to a smaller absolute benefit at lower baseline risk.
Common pitfall: Saying that a 50% relative reduction prevents events in half of all treated people confuses a proportional reduction with an absolute population effect.
Dermatology4% (8/200; indicative)
18.Which skin findings favour plaque psoriasis?
Plaque psoriasis produces raised, scaly skin lesions and commonly affects areas such as the elbows, knees, scalp and lower back. Appearance varies with skin colour, so redness alone is an unreliable defining feature. Distribution, persistent scale and associated nail changes strengthen recognition. The useful distinction is between an isolated nonspecific rash description and a coherent pattern across skin sites, nails and possible inflammatory joint symptoms.
Apply it
A patient has persistent scaly plaques over both elbows and the scalp, with small pits in several fingernails. Use the combined distribution and nail findings to favour psoriasis rather than relying only on whether the plaques appear red.
Common pitfall: Requiring every psoriatic plaque to look bright red can impair recognition across skin tones. Site, scale and nail findings provide additional discriminating evidence.
19.When should joint symptoms in psoriasis prompt assessment?
Psoriasis can be associated with psoriatic arthritis, so joint pain, swelling or stiffness should not automatically be attributed to mechanical wear. Nail abnormalities and known skin disease provide context but do not alone establish the cause of joint symptoms. The decision is to recognise a possible inflammatory musculoskeletal complication and arrange assessment. Skin severity and joint disease burden need not be assumed to track together in an individual patient.
Apply it
A patient with limited scalp psoriasis reports swollen fingers and persistent morning stiffness. Recognise possible psoriatic arthritis and arrange assessment even though the visible skin disease occupies only a small area and causes little discomfort.
Common pitfall: Dismissing joint symptoms because psoriasis is mild can delay recognition of inflammatory arthritis. Conversely, psoriasis does not prove that every painful joint is psoriatic.
Endocrinology, diabetes and metabolic medicine7% (14/200; indicative)
20.How does ACTH distinguish primary from central adrenal insufficiency?
Cortisol restrains pituitary ACTH secretion through negative feedback. Primary adrenal failure produces low cortisol with raised ACTH because the failing gland cannot respond adequately. Low cortisol with inappropriately low or normal ACTH suggests a central cause. Once primary failure is established, adrenal autoantibodies can support autoimmune Addison's disease; this cause-finding investigation does not replace hormone assessment.
Apply it
Low cortisol with markedly elevated ACTH supports primary adrenal failure. Investigate an autoimmune cause after establishing the functional diagnosis, rather than using an antibody test as a substitute for cortisol and ACTH interpretation.
Common pitfall: An ACTH result within its reference range can still be physiologically inadequate when cortisol is low. Negative adrenal antibodies do not themselves exclude adrenal insufficiency.
Diagnosis of Adrenal Insufficiency & Addison's Disease — NIDDK
21.What does ACTH stimulation test, and why can recent pituitary disease give a reassuring response?
Administered ACTH challenges adrenal cortisol production while bypassing endogenous pituitary ACTH secretion. Soon after pituitary damage, the adrenal glands may retain responsiveness despite inadequate endogenous stimulation. A normal stimulation response therefore does not reliably exclude recent secondary adrenal insufficiency. With prolonged ACTH deficiency, adrenal responsiveness can decline. Interpret the test according to the site of the suspected defect and the interval since it developed.
Apply it
A patient becomes unwell shortly after pituitary surgery, but cortisol rises during ACTH stimulation. Recognise that preserved early adrenal capacity does not establish adequate pituitary ACTH function.
Common pitfall: Calling ACTH stimulation a direct test of pituitary reserve mistakes the organ being challenged. A normal response has different implications in recent central disease and longstanding primary failure.
Diagnosis of Adrenal Insufficiency & Addison's Disease — NIDDK
22.Which autoimmune endocrine diagnoses warrant coeliac serology at diagnosis?
NICE recommends offering coeliac serology at diagnosis of type 1 diabetes or autoimmune thyroid disease. Coeliac disease may present through nutritional deficiency or other extraintestinal features, so absence of diarrhoea is not a reason to disregard this recommendation. Initial testing uses total IgA and IgA tissue transglutaminase, with an IgG-based strategy when IgA is deficient.
Apply it
A patient newly diagnosed with type 1 diabetes denies gastrointestinal symptoms. Offer coeliac serology rather than waiting for diarrhoea or weight loss to appear.
Common pitfall: Restricting coeliac testing to symptomatic gastrointestinal disease misses an explicit indication associated with autoimmune endocrine disease.
Recommendations | Coeliac disease: recognition, assessment and management | Guidance | NICE
23.When should unexplained metabolic bone disease prompt investigation beyond calcium intake?
Reduced bone mineral density or osteomalacia can justify consideration of coeliac serology, particularly when accompanied by unexplained nutritional deficiency. The investigation asks whether an underlying intestinal disorder contributes to the bone problem. In confirmed coeliac disease, review bone health and assess whether DEXA or active treatment of bone disease is needed. Finding a skeletal abnormality should therefore prompt assessment of potential causes as well as its consequences.
Apply it
A patient has unexplained low bone mineral density and persistent iron deficiency without prominent bowel symptoms. Consider coeliac testing as part of the aetiological assessment.
Common pitfall: A lack of diarrhoea does not exclude an intestinal contributor to metabolic bone disease. Bone density measurement describes a consequence without necessarily identifying its cause.
Recommendations | Coeliac disease: recognition, assessment and management | Guidance | NICE
Gastroenterology and Hepatology7% (14/200; indicative)
24.Why must gluten consumption continue during coeliac testing?
Coeliac investigations depend on an immune response and intestinal changes associated with gluten exposure. Removing gluten can lower antibodies and allow intestinal recovery, reducing diagnostic sensitivity. NICE advises people following a normal diet to eat some gluten in more than one meal daily for at least six weeks before testing and to continue gluten during investigation. If someone cannot or will not reintroduce gluten, specialist assessment is needed because confirmation may be difficult.
Apply it
A patient plans to stop gluten immediately before testing. Explain the effect on diagnostic accuracy and agree the investigation plan before dietary exclusion.
Common pitfall: A negative result after gluten avoidance is not equivalent to a negative result during adequate exposure. Symptomatic improvement on exclusion alone does not confirm coeliac disease.
Coeliac disease: Diagnosis — NHS · Recommendations | Coeliac disease: recognition, assessment and management | Guidance | NICE
25.Which coeliac antibody tests should be requested, and how does IgA deficiency change interpretation?
For young people and adults, request total IgA with IgA tissue transglutaminase as first-line tests. Use IgA endomysial antibodies when IgA tTG is weakly positive. If IgA is deficient, consider IgG EMA, IgG deamidated gliadin peptide or IgG tTG. IgA deficiency can make IgA-based testing falsely negative; inadequate gluten exposure is another cause of reduced sensitivity. Persistent clinical suspicion despite negative serology warrants gastrointestinal specialist assessment.
Apply it
A patient with weight loss and deficiencies has negative IgA tTG. Check total IgA and gluten exposure. An IgA-deficient patient needs an appropriate IgG-based investigation rather than reassurance from the IgA result.
Common pitfall: A negative IgA antibody result is not reassuring when the patient cannot produce enough IgA. Total IgA and the disease-specific IgA antibody answer different questions.
Recommendations | Coeliac disease: recognition, assessment and management | Guidance | NICE · Coeliac disease: Diagnosis — NHS
26.How do antibody testing and intestinal biopsy contribute differently?
Coeliac blood tests look for an associated antibody response, whereas small-intestinal biopsy assesses tissue changes directly. These are complementary forms of evidence rather than interchangeable measurements. In the diagnostic pathway described for adults, positive blood testing commonly leads to specialist assessment and biopsy to confirm disease. Persisting suspicion may also justify specialist investigation after negative antibodies. Interpret both investigations in the context of gluten exposure and the patient's clinical features.
Apply it
An adult with persistent diarrhoea has positive coeliac antibodies and asks why endoscopy may still be discussed. Explain that the blood test identifies an immune signal, while intestinal sampling can establish the associated tissue changes.
Common pitfall: Assuming that an antibody measurement directly demonstrates intestinal histology confuses two evidence types. Symptomatic improvement after dietary change also does not itself provide tissue confirmation.
Coeliac disease: Diagnosis — NHS · Recommendations | Coeliac disease: recognition, assessment and management | Guidance | NICE
27.Why can hereditary haemochromatosis affect several organs?
Hereditary haemochromatosis causes inappropriate iron accumulation, with excess iron stored in tissues including the liver, heart, pancreas and joints. Clinical findings can therefore cross specialty boundaries rather than presenting as isolated liver disease. The unifying clue is a pattern compatible with systemic iron overload. Genetic subtype influences the underlying disorder, but symptoms alone cannot establish which gene is responsible or whether a particular family member has inherited it.
Apply it
A patient has liver disease alongside diabetes and chronic joint symptoms, with evidence of iron overload. Consider a systemic iron-loading disorder that can connect these findings rather than assuming that each organ problem necessarily has an unrelated cause.
Common pitfall: Restricting haemochromatosis to hepatic disease misses its multisystem expression. A suggestive clinical pattern also cannot substitute for appropriate biochemical and genetic evaluation of the suspected disorder.
Geriatric medicine4% (8/200; indicative)
28.How is hypoactive delirium recognised?
Delirium is an acute, often fluctuating disturbance of mental functioning with impaired attention. It may present with agitation, but it can also produce quietness, drowsiness, reduced interaction or slowed responses. Hypoactive delirium is easily missed because the patient is not disruptive. A change from baseline over a short period and variable concentration are more discriminating than whether the patient appears restless, particularly in someone with pre-existing cognitive impairment.
Apply it
An older inpatient becomes unusually quiet after an acute illness, drifts off during conversation and performs inconsistently across the day. Obtain collateral information about baseline function and assess for delirium rather than interpreting calm behaviour as clinical stability.
Common pitfall: Requiring agitation to diagnose delirium misses hypoactive cases. Longstanding dementia also does not prevent an additional acute delirium from developing during illness.
Delirium: Overview — Guy's and St Thomas' NHS Foundation Trust
29.Why does delirium prevention combine several practical measures?
Delirium risk is influenced by interacting problems such as disorientation, poor sleep, immobility, dehydration and impaired hearing or vision. Prevention therefore combines practical measures rather than relying on one intervention. Accessible glasses and hearing aids improve communication; familiar orientation cues, hydration, movement and a supportive sleep routine reduce avoidable burdens. The useful decision is to identify modifiable contributors for the individual patient and maintain these measures consistently during hospital care.
Apply it
An older patient at risk of delirium has hearing aids left at home, little daytime movement and frequent nighttime interruptions. Arrange sensory aids, supported activity and a better sleep routine alongside hydration and regular orientation during admission.
Common pitfall: Treating prevention as a single orientation conversation overlooks repeated environmental and physiological stresses. Measures must also be adapted to the patient's mobility and safety needs.
How to prevent delirium and help your recovery — Guy's and St Thomas' NHS Foundation Trust
Haematology5% (10/200; indicative)
30.What does macrocytosis contribute to assessing vitamin deficiency?
Vitamin B12 or folate deficiency can produce abnormally large red blood cells and anaemia, making macrocytosis a useful clue. However, a blood count pattern is not a complete diagnosis: symptoms, nutritional history and investigation of the underlying cause remain important. B12 deficiency can also cause neurological disease, which helps distinguish its consequences from uncomplicated folate deficiency. Interpret the cell size alongside clinical findings rather than treating macrocytosis as a disease name.
Apply it
A patient has an increased mean cell volume, fatigue and tingling feet. Investigate vitamin B12 deficiency as part of the assessment, linking the neurological symptoms with the blood findings rather than attributing the entire picture to anaemia alone.
Common pitfall: Macrocytosis suggests a category of problems rather than proving a specific deficiency. Neurological findings require attention even when the degree of anaemia appears modest.
Vitamin B12 or folate deficiency anaemia — NHS · Vitamin B12–Deficiency Anemia — NHLBI
31.Why does a normal haemoglobin not exclude B12 deficiency?
Vitamin B12 deficiency affects more than red cell production. Neurological symptoms, including altered sensation and problems with balance or cognition, can occur without anaemia. A normal haemoglobin therefore does not exclude a clinically important deficiency when the symptom pattern is compatible. The decision is to investigate the suspected deficiency on its clinical merits rather than using one normal haematological measurement as a universal exclusion test for neurological consequences.
Apply it
A patient with progressive tingling and impaired balance has a haemoglobin within the laboratory range. Keep vitamin B12 deficiency in the assessment because neurological involvement can occur before, or without, a recognisable anaemia on the blood count.
Common pitfall: Using normal haemoglobin to dismiss B12 deficiency confuses one manifestation with the entire disorder. The absence of anaemia does not establish adequate neurological B12 function.
Vitamin B12 or folate deficiency anaemia — NHS · Vitamin B12–Deficiency Anemia — NHLBI
32.How does pernicious anaemia impair B12 absorption?
Intrinsic factor is a stomach-derived protein needed for normal intestinal absorption of vitamin B12. In pernicious anaemia, an autoimmune process disrupts this absorption pathway, so adequate dietary B12 may not prevent deficiency. The mechanism distinguishes malabsorption from insufficient intake. Recognising it changes the explanation given to a patient: eating more B12-containing food does not necessarily overcome loss of the physiological system required to absorb the vitamin normally.
Apply it
A patient eats meat and dairy regularly but develops B12 deficiency with evidence supporting pernicious anaemia. Explain that the problem can be impaired absorption through the intrinsic-factor pathway rather than a simple lack of vitamin in the diet.
Common pitfall: Assuming that a varied diet excludes B12 deficiency overlooks malabsorption. Dietary adequacy and the ability to absorb a nutrient are separate physiological questions.
Vitamin B12–Deficiency Anemia — NHLBI · Vitamin B12 or folate deficiency anaemia — NHS
Infectious diseases7% (14/200; indicative)
33.Which hepatitis B pattern supports acute infection?
A typical acute hepatitis B pattern includes positive HBsAg, positive total anti-HBc, positive IgM anti-HBc and negative anti-HBs. Surface antigen indicates current infection, while IgM core antibody supports recent infection in an appropriate clinical setting. However, IgM anti-HBc can also become positive during severe flares or reactivation of chronic infection. Clinical history and previous results therefore remain necessary before assigning a new acute infection solely from this marker.
Apply it
A patient with a recent exposure and no known previous infection has HBsAg and IgM anti-HBc detected. Acute infection is supported, but ask about prior hepatitis B results before assuming that the IgM result proves first acquisition.
Common pitfall: Treating IgM anti-HBc as an infallible timestamp ignores its possible appearance during chronic hepatitis B flares or reactivation, especially when prior infection is documented.
34.How is chronic hepatitis B distinguished from a single positive surface antigen?
HBsAg positivity identifies current hepatitis B infection but does not, by itself, establish how long infection has been present. Persistence of HBsAg for at least six months supports chronic infection. A common chronic pattern includes positive total anti-HBc, negative anti-HBs and usually negative IgM anti-HBc outside a flare. The key discriminator is chronicity: combine the current pattern with previous results rather than inferring duration from a single antigen measurement.
Apply it
A patient remains HBsAg positive seven months after an earlier positive result. The documented persistence supports chronic hepatitis B, whereas an isolated first positive HBsAg result would identify current infection without establishing the same duration.
Common pitfall: Calling every first positive HBsAg result chronic disease overstates what the test measures. Surface antigen identifies current infection, while previous results establish persistence.
35.How does suspected active pulmonary tuberculosis differ from latent infection?
A cough lasting more than three weeks with weight loss, fever or night sweats should prompt assessment for active tuberculosis, particularly with relevant exposure. Chest imaging and respiratory samples investigate symptomatic pulmonary disease. Latent infection has no symptoms and is not transmissible, although it can later become active. Skin or blood testing used after exposure does not replace investigation of symptomatic disease. See the [NHS tuberculosis guidance](https://www.nhs.uk/conditions/tuberculosis-tb/).
Apply it
A household contact develops a four-week cough, night sweats and weight loss. Investigate possible active pulmonary disease rather than treating the situation only as asymptomatic exposure screening.
Common pitfall: A label of latent infection requires exclusion of active disease. Symptoms cannot be dismissed merely because an earlier assessment concerned latent infection.
36.Why is isolated hepatitis B core antibody not a single diagnosis?
An isolated total anti-HBc result means HBsAg and anti-HBs are negative while core antibody is positive. Possible explanations include previous infection with waned surface antibody, a false-positive result, occult infection or the window period of acute infection. The pattern therefore needs clinical context and, where appropriate, additional investigation. Exposure history, immune status and previous serology help discriminate among explanations rather than allowing one marker to settle the diagnosis.
Apply it
Before immunosuppressive treatment, a patient has isolated total anti-HBc. Review previous infection and vaccination records and assess the need for further hepatitis B evaluation instead of labelling the patient automatically as either immune or actively infected.
Common pitfall: An isolated core antibody is neither universal proof of acute infection nor a simple vaccine response. Several biologically different states can produce this pattern.
Neurology7% (14/200; indicative)
37.Which ocular symptoms suggest myasthenia gravis?
Myasthenia gravis commonly causes fluctuating ptosis and double vision through weakness of eyelid and eye movement muscles. Symptoms often become more noticeable with use and improve after rest. The pattern is more discriminating than either symptom in isolation, because ptosis and diplopia have other causes. Ask about variation during the day and associated chewing, swallowing, speech or limb weakness to determine whether involvement extends beyond the ocular muscles.
Apply it
A patient reports intermittent double vision and an eyelid that droops after prolonged reading but improves after resting. Ask about fatigability and other muscle groups, using the fluctuation to support a neuromuscular junction disorder.
Common pitfall: A single photograph of ptosis may conceal the defining fluctuation. Conversely, double vision without the broader pattern does not by itself establish myasthenia gravis.
38.How does bulbar myasthenia alter clinical concern?
Myasthenia can weaken muscles involved in chewing, swallowing and speaking. Symptoms may worsen during a meal or prolonged conversation, reflecting fatigable muscle performance. These findings are clinically important because swallowing impairment can threaten safe intake and may accompany more extensive weakness. A history focused only on eyes or limbs can miss substantial disease. Ask specifically about meal-related fatigue, changing speech quality and difficulty managing swallowing during symptomatic periods.
Apply it
A patient with fluctuating ptosis says that chewing becomes difficult near the end of dinner and speech weakens after long conversations. Recognise bulbar involvement and assess swallowing and the extent of weakness rather than considering the disease purely ocular.
Common pitfall: Attributing meal difficulty solely to appetite or dental problems overlooks fatigable chewing and swallowing weakness, particularly when compatible ocular symptoms are already present.
39.When does myasthenic weakness require emergency assessment?
Myasthenia gravis can affect respiratory muscles and cause potentially life-threatening breathing difficulty. New or severe breathlessness, especially with worsening swallowing or generalised weakness, requires urgent assessment rather than routine follow-up. The dangerous mechanism is failure of neuromuscular transmission in muscles needed for ventilation. Previous mild or predominantly ocular disease does not guarantee that later deterioration will remain limited to the eyes or follow the same severity pattern.
Apply it
A patient with known myasthenia develops worsening swallowing and new difficulty breathing over several hours. Arrange emergency assessment for possible respiratory muscle involvement rather than scheduling a routine review based on the previously mild disease history.
Common pitfall: Judging present risk from the patient's usual symptom pattern can miss deterioration. Respiratory and bulbar changes carry a different urgency from stable intermittent eyelid drooping.
40.How can myasthenia be investigated when antibody testing is negative?
Myasthenia investigation combines the clinical pattern with antibody testing and, when needed, electrical testing of nerve-to-muscle transmission. A negative antibody result does not exclude every case, particularly ocular disease. Neurophysiological testing can provide evidence of impaired transmission. Chest CT or MRI can investigate associated thymic abnormalities, including thymoma. These tests address different questions: whether transmission is defective and whether an associated structural abnormality is present.
Apply it
A patient has reproducible fluctuating ptosis and chewing weakness but negative initial antibodies. Arrange specialist assessment and appropriate neurophysiological investigation; consider thymic imaging within the diagnostic assessment.
Common pitfall: Neither negative antibodies nor a normal thymic scan universally excludes myasthenia. A thymic scan is not a direct test of neuromuscular transmission.
Oncology2.5% (5/200; indicative)
41.How do laboratory and clinical tumour lysis syndrome differ in the Cairo–Bishop framework?
Cairo–Bishop laboratory tumour lysis requires at least two qualifying abnormalities from three days before to seven days after treatment. Adult absolute thresholds are urate ≥0.476, potassium ≥6.0, phosphate ≥1.45 and corrected calcium ≤1.75 mmol/L. The framework also recognises qualifying 25% changes from baseline: increases in urate, potassium or phosphate, or a calcium decrease. Clinical tumour lysis adds creatinine ≥1.5 times the upper reference limit, cardiac arrhythmia/sudden death or seizure, with the complication not directly or probably attributable to a therapeutic agent.
Apply it
Two days after treatment, urate is 0.60 mmol/L and potassium 6.2 mmol/L. These establish laboratory tumour lysis. Creatinine of 180 µmol/L with an upper reference limit of 100 µmol/L establishes a qualifying renal complication when attributable to lysis.
Common pitfall: One abnormal analyte does not establish laboratory tumour lysis. Unspecified kidney injury does not demonstrate the formal clinical threshold, and direct drug toxicity must be distinguished from lysis-related injury.
Prevention of tumour lysis syndrome — eviQ, Cancer Institute NSW
Medical ophthalmology2% (4/200; indicative)
42.Which visual symptoms demand urgent assessment for retinal detachment?
A sudden increase in floaters, flashes of light or a dark shadow or curtain across the visual field can indicate retinal detachment. Detachment may be painless, so absence of pain does not reduce the significance of these symptoms. Urgent assessment is needed because untreated separation threatens permanent vision. The discriminating pattern is an abrupt change suggesting retinal traction or field loss rather than slowly progressive blur without these warning features.
Apply it
A patient notices many new floaters followed by flashes and a shadow advancing across one eye's vision. Arrange urgent eye assessment even though there is no pain and the patient can still see through part of the field.
Common pitfall: Waiting for pain or complete blindness delays recognition. Retinal detachment can threaten vision while the eye remains comfortable and only part of the field is affected.
43.How do retinal detachment risk factors change symptom interpretation?
Retinal detachment risk is increased by factors including severe short-sightedness, previous eye surgery or injury, and a personal or family history of detachment. These factors raise concern when warning symptoms appear, but they are not required for the diagnosis. Risk history modifies suspicion rather than acting as a gatekeeper for urgent assessment. New flashes, floaters or a visual curtain deserve attention even when the patient has no recognised predisposing condition.
Apply it
A severely short-sighted patient develops sudden flashes after previous eye surgery. The risk history strengthens concern, but explain that a person without these factors would still need urgent assessment for the same new visual warning symptoms.
Common pitfall: Using absence of risk factors to dismiss a visual curtain mistakes probability modifiers for exclusion criteria. Symptoms can identify an emergency without a classic risk history.
Palliative medicine and end of life care2% (4/200; indicative)
44.How should comfort care change when swallowing becomes difficult near death?
People approaching death may become less interested in food and drink and may have difficulty swallowing. Care should prioritise comfort, including mouth and lip care, assistance when swallowing remains safe, and review of how necessary medicines are given. Forcing oral intake can cause distress when the person can no longer manage it. The relevant decision is whether an intervention improves comfort and is feasible in the person's current condition.
Apply it
A dying patient is drowsy and cannot comfortably swallow tablets or drinks. Provide mouth care and ask the clinical team to review medicine routes rather than repeatedly encouraging oral intake that the patient can no longer manage safely.
Common pitfall: Equating good care with forcing food, fluid or tablets ignores changing swallowing ability. Comfort and individual assessment should guide what is offered and how.
45.Why can breathing become irregular or noisy in the last days?
Breathing near death may become shallow or irregular, with pauses, and secretions can create a rattling sound when the person is too weak to clear them. The sound can distress relatives without necessarily indicating that the patient is suffering. Explain the expected change while assessing the person's actual comfort. Repositioning and appropriate clinical review may help; the noise itself should not substitute for observation of distress or an individual care assessment.
Apply it
Relatives are alarmed by pauses and rattling breathing in a patient already assessed as dying. Explain these possible changes, assess comfort and consider positioning with the care team rather than assuming the sound alone proves suffering.
Common pitfall: Either declaring every breathing sound painful or dismissing all breathing changes without assessment is misleading. Expected changes still require attention to the individual's comfort.
Psychiatry4.5% (9/200; indicative)
46.Which symptom syndrome, duration and severity distinguish mania from hypomania?
In DSM-style criteria, both episodes require a distinct period of abnormally elevated, expansive or irritable mood together with increased activity or energy, present most of the day nearly every day. During that period, at least three qualifying symptoms must persist to a significant degree and represent a noticeable change from usual behaviour; require four if mood is only irritable. The symptoms are inflated self-esteem or grandiosity; decreased need for sleep; increased talkativeness or pressure to keep talking; racing thoughts or flight of ideas; distractibility; increased goal-directed activity or psychomotor agitation; and excessive involvement in activities with potentially painful consequences, such as reckless spending. Mania lasts at least seven days, or any duration if hospitalisation is necessary, and causes marked impairment, requires hospitalisation or includes psychosis. Hypomania lasts at least four consecutive days, causes an unequivocal change in functioning observable by others, and does not cause marked impairment, require hospitalisation or include psychosis. Exclude episodes attributable to substances, medicines or another medical condition. The [DSM comparison table](https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t7/) sets out the manic syndrome requirements.
Apply it
Eight days of sustained abnormal expansive mood and increased energy, with decreased need for sleep, pressured speech, reckless spending and grandiose delusions causing hospital admission, support mania after exclusions. Four days of the required mood, energy and symptom syndrome with an observable change but no psychosis or marked impairment may support hypomania.
Common pitfall: Several energetic days or reduced sleep alone do not establish hypomania. Establish the mandatory mood and energy change, symptom count, persistence and exclusions before using duration and severity to classify the episode.
Bipolar Disorder — NIMH · Psychiatry.org - What Are Bipolar Disorders?
47.Which episode history distinguishes bipolar I from bipolar II disorder?
Bipolar I disorder requires at least one manic episode; a major depressive episode is not required. Bipolar II disorder requires at least one hypomanic episode and at least one major depressive episode, with no history of mania. A major depressive episode requires at least five of nine symptoms during the same two-week period, representing a change from previous functioning. These are depressed mood; markedly diminished interest or pleasure; appetite or significant weight change; insomnia or hypersomnia; observable psychomotor agitation or slowing; fatigue; worthlessness or excessive or inappropriate guilt; impaired concentration or indecisiveness; and recurrent thoughts of death, suicidal ideation or suicidal behaviour. At least one qualifying symptom must be depressed mood or markedly diminished interest or pleasure, occurring most of the day, nearly every day. Most other qualifying symptoms must also occur nearly every day; significant weight change and recurrent thoughts of death, suicidal ideation or suicidal behaviour do not require this daily frequency. Symptoms must cause clinically significant distress or impairment and must not be attributable to a substance or another medical condition.
Apply it
A patient with previous hypomania reports three weeks of anhedonia most of the day, nearly every day, accompanied by nearly daily insomnia, fatigue, worthlessness and poor concentration that substantially impair work. This supplies five qualifying depressive symptoms and supports the depressive episode requirement for bipolar II, provided the other diagnostic requirements are satisfied and there has never been mania. A documented previous manic episode instead establishes the defining episode history for bipolar I.
Common pitfall: Five symptoms occurring only intermittently somewhere within two weeks do not necessarily establish a major depressive episode. Check each symptom's frequency as well as duration and impact. Hypomania plus nonsyndromal low mood does not establish bipolar II, and assessing only the current depressive presentation can miss decisive previous mania.
Bipolar Disorder — NIMH · Psychiatry.org - What Are Bipolar Disorders?
48.What does rapid cycling mean in bipolar disorder, and how are separate episodes counted?
Rapid cycling is a course specifier for bipolar I or bipolar II disorder requiring at least four qualifying manic, hypomanic or major depressive episodes during the preceding 12 months. Each counted episode must meet its syndromal criteria, including the applicable duration and severity requirements. Episodes are demarcated by partial or full remission lasting at least two months, or by a switch to an episode of opposite polarity. Major depression and mania or hypomania represent opposite poles, so a qualifying switch between them can separate episodes without an intervening remission. Mania followed by hypomania alone is not an opposite-polarity switch.
Apply it
Timeline: January contains a three-week major depressive episode immediately followed by a six-day hypomanic episode; February and March contain full remission; April contains another three-week major depressive episode immediately followed by another six-day hypomanic episode. Assuming each episode meets its full criteria, four episodes have occurred within 12 months. The depression-to-hypomania switches demarcate episodes within each pair, while the remission lasting at least two months separates the pairs.
Common pitfall: Do not count hourly emotional fluctuations, residual depressive symptoms or brief incomplete improvement as additional syndromal episodes. A manic episode subsiding directly into hypomanic symptoms does not become two episodes merely because the intensity changes: without at least two months of partial or full remission, that same-polarity transition does not demarcate another episode.
Bipolar Disorder — NIMH · Characteristics of rapid cycling in 1261 bipolar disorder patients - PMC
Renal medicine7% (14/200; indicative)
49.When does an abnormal kidney result establish chronic kidney disease?
Chronic kidney disease requires abnormalities of kidney structure or function present for at least three months and relevant to health. A single low estimated GFR or elevated albumin-to-creatinine ratio cannot automatically establish chronicity. Previous measurements, imaging, history or repeat assessment can provide evidence of duration. The decision is to distinguish persistent disease from an acute or transient abnormality before assigning a chronic diagnosis, while still evaluating urgent abnormalities without delay.
Apply it
An otherwise undocumented eGFR of 48 mL/min/1.73 m² is measured during an acute illness. Review earlier records and reassess appropriately rather than immediately labelling the finding chronic kidney disease solely from this one result.
Common pitfall: Waiting to establish chronicity must not delay assessment of possible acute kidney injury. Conversely, one abnormal value does not establish a chronic diagnosis by itself.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
50.How are GFR categories used without overdiagnosing CKD?
KDIGO GFR categories are G1 at 90 or above, G2 at 60–89, G3a at 45–59, G3b at 30–44, G4 at 15–29 and G5 below 15 mL/min/1.73 m². G1 and G2 do not establish CKD without another marker of kidney damage. A category describes filtration, whereas the diagnosis also requires the appropriate abnormality and chronicity. Classification should therefore follow, rather than replace, diagnostic reasoning.
Apply it
A patient has an eGFR of 76 mL/min/1.73 m², no albuminuria and no other identified kidney abnormality. Recognise the G2 filtration category but do not infer CKD from that category alone without additional qualifying evidence.
Common pitfall: Calling every G2 result stage 2 CKD ignores the requirement for kidney damage. Filtration category and a complete chronic kidney disease diagnosis are different statements.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
51.Which albuminuria thresholds distinguish A1, A2 and A3?
Urine albumin-to-creatinine ratio is classified as A1 below 3 mg/mmol, A2 at 3–30 mg/mmol and A3 above 30 mg/mmol. Corresponding thresholds are below 30, 30–300 and above 300 mg/g. The units are not interchangeable numerically. Albuminuria complements GFR because significant kidney damage can exist with preserved filtration. Confirm persistence and interpret the category alongside cause and GFR rather than describing kidney disease from filtration alone.
Apply it
A patient has persistent urine ACR of 12 mg/mmol with preserved eGFR. Classify the albuminuria as A2 and recognise that preserved filtration does not remove the significance of a persistent marker of kidney damage.
Common pitfall: Comparing an mg/mmol value directly with an mg/g threshold causes misclassification. Also, a single elevated ACR needs interpretation before persistent albuminuria is assumed.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
52.How do the main renal tubular acidoses differ?
Renal tubular acidosis reflects impaired tubular acid-base handling. Distal, or type 1, disease impairs acid excretion; proximal, or type 2, disease impairs bicarbonate reclamation. Type 4 disease is associated with impaired aldosterone production or action and characteristically high potassium. These are mechanistically different routes to metabolic acidosis. Potassium and the affected transport process help discriminate them, rather than treating all acidosis attributed to the kidneys as one uniform disorder.
Apply it
A patient with metabolic acidosis has hyperkalaemia and evidence suggesting reduced aldosterone effect. Type 4 RTA fits this combination better than a primary proximal bicarbonate-reclamation defect; use the potassium finding to guide the mechanistic differential.
Common pitfall: Assuming that all RTA causes hypokalaemia loses an important discriminator. Distal acid secretion, proximal bicarbonate recovery and aldosterone-related handling are distinct physiological problems.
Respiratory medicine7% (14/200; indicative)
53.What does the FEV1/FVC ratio measure?
FEV1 is the volume exhaled during the first second of a forced expiration, while FVC is the total volume exhaled during that manoeuvre. Their ratio expresses how much of the forced volume leaves in the first second. A reduced ratio supports airflow obstruction because early expiratory flow is disproportionately limited. Read the ratio separately from FEV1 relative to predicted, which describes the extent of airflow limitation after the pattern is established.
Apply it
Spirometry records FEV1 of 1.5 litres and FVC of 3.0 litres. Calculate an FEV1/FVC ratio of 0.50 and interpret it with test quality, post-bronchodilator measurements and clinical context.
Common pitfall: Using FEV1 alone to identify the ventilatory pattern overlooks its relationship with FVC. A reduced volume does not, by itself, specify why it is reduced.
COPD: Diagnosis — NHS · Recommendations | Chronic obstructive pulmonary disease in over 16s: diagnosis and management | Guidance | NICE
54.Which clinical features favour asthma over COPD when airflow obstruction is present?
Asthma is favoured by onset at a younger age, nocturnal waking and substantial day-to-day or diurnal symptom variability. COPD more often produces persistent progressive breathlessness and chronic productive cough with relevant exposure. NICE identifies a bronchodilator FEV1 increase over 400 mL or serial peak-flow variability of at least 20% as findings that can help identify asthma when uncertainty remains. Interpret these findings longitudinally; a single reversibility result is not a perfect separator.
Apply it
A patient has variable wheeze, frequent nocturnal waking and marked peak-flow variability. These findings favour asthma over attributing all obstruction to smoking-related COPD.
Common pitfall: Some bronchodilator improvement can occur in COPD. Conversely, smoking does not exclude asthma or coexistence of the two disorders.
55.Why are COPD symptoms insufficient to establish the diagnosis?
Persistent breathlessness, cough and sputum can suggest COPD, particularly with a relevant exposure history, but these symptoms overlap with other respiratory and cardiac disorders. Spirometry provides objective assessment of airflow obstruction. Other tests, including chest imaging or blood tests, may investigate alternative or additional explanations. The decision is to connect symptoms with demonstrated physiology rather than diagnosing COPD solely from smoking history or a nonspecific symptom such as chronic breathlessness.
Apply it
A smoker has progressive breathlessness but no previous lung function testing. Arrange diagnostic assessment including spirometry rather than assigning COPD from smoking alone, while considering whether other findings suggest an additional cardiac, haematological or pulmonary explanation.
Common pitfall: Smoking history increases suspicion but does not prove COPD. A familiar risk factor should not replace objective testing or evaluation of competing explanations for breathlessness.
56.Which post-bronchodilator threshold supports COPD, and what are its limitations?
The conventional criterion for persistent obstruction is a post-bronchodilator FEV1/FVC ratio below 0.70 in an appropriate clinical context. The ratio normally changes with age: a fixed threshold can overidentify obstruction in older people and miss clinically relevant disease in younger people. NICE advises considering alternatives in older people with a ratio below 0.70 but no typical symptoms, and considering COPD in symptomatic younger people even when the ratio exceeds 0.70.
Apply it
A symptomatic smoker has a technically satisfactory post-bronchodilator ratio of 0.58, supporting persistent obstruction. An asymptomatic older person with a borderline low ratio requires clinical interpretation rather than an automatic COPD label.
Common pitfall: The threshold does not replace assessment of symptoms, exposure and test quality. Discordance between measurements and symptoms should prompt reconsideration or further investigation.
Recommendations | Chronic obstructive pulmonary disease in over 16s: diagnosis and management | Guidance | NICE · COPD: Diagnosis — NHS
Rheumatology7% (14/200; indicative)
57.When should an acutely inflamed joint raise concern for infection?
A rapidly painful, swollen joint can represent gout, but joint infection must be considered, particularly when the patient also has fever, systemic illness or worsening symptoms. Clinical overlap makes a previous gout diagnosis insufficient reassurance. When infection is suspected, urgent assessment and appropriate joint investigation are needed. The key decision is to recognise the consequence of missing infection rather than choosing a familiar crystal diagnosis solely because it has occurred before.
Apply it
A patient with previous gout develops a hot swollen knee, fever and increasing systemic illness. Arrange urgent assessment for possible joint infection rather than assuming this episode has the same cause as earlier uncomplicated attacks.
Common pitfall: A history of gout does not exclude septic arthritis. Fever and systemic deterioration should not be dismissed simply because a crystal diagnosis appears familiar.
Gout — NHS · Joint aspiration — Chelsea and Westminster Hospital NHS Foundation Trust
58.Why can serum urate mislead during an acute gout flare, and when should it be repeated?
Serum urate can fall during an acute flare, so a low result does not reliably exclude gout. When gout remains strongly suspected despite a result below 360 µmol/L, repeat measurement at least two weeks after the flare has settled. An elevated concentration supports the clinical assessment but does not alone prove that gout causes the current arthritis. These timing recommendations are specified in [NICE NG219](https://www.nice.org.uk/guidance/ng219/chapter/Recommendations).
Apply it
During a typical acute attack, serum urate is 320 µmol/L. Retain gout in the differential and arrange repeat testing at least two weeks after the flare has settled, while investigating infection urgently if suspected.
Common pitfall: Hyperuricaemia is a biochemical finding, not proof of the cause of every swollen joint. Repeating urate later must not delay investigation of possible septic arthritis.
Gout — NHS · Recommendations | Gout: diagnosis and management | Guidance | NICE
59.Which synovial fluid analyses distinguish infection from crystal arthritis?
Request bacterial identification with culture and Gram staining, synovial white-cell count with differential, and crystal analysis. Crystals do not exclude concurrent infection, and a negative Gram stain does not exclude infection because its sensitivity is limited. The [SANJO guideline](https://jbji.copernicus.org/articles/8/29/2023/) prioritises bacterial identification when sample volume is limited. Obtain diagnostic samples promptly before antibiotics when feasible in a stable patient; suspected sepsis requires immediate treatment without waiting for aspiration or culture results.
Apply it
An aspirate contains crystals but the patient remains febrile and systemically unwell. Continue infection assessment, including culture, rather than treating the crystal result as an exclusion test for septic arthritis.
Common pitfall: Neither crystals, a negative Gram stain nor an isolated cell count safely rules out infection. Sample collection must not delay antibiotics in sepsis or septic shock.
Joint aspiration — Chelsea and Westminster Hospital NHS Foundation Trust · Gout — NHS
60.How do gout flare treatment and urate lowering address different problems?
Treatment of an acute gout attack aims to reduce current inflammation and pain, whereas urate-lowering treatment aims to reduce the underlying urate burden and prevent future attacks. These are different timescales and objectives. Relief of today's pain does not show that the long-term biochemical predisposition has been corrected. Conversely, a preventive strategy should not be judged solely by whether it provides immediate analgesia during a single active inflammatory episode.
Apply it
A patient feels better after treatment for an acute gout attack and asks whether recurrent attacks are now prevented. Explain that symptom relief and long-term urate control are separate goals that may require different parts of the management plan.
Common pitfall: Assuming that pain relief removes the cause of recurrent gout confuses suppression of inflammation with reduction of urate burden. Preventive treatment serves a longer-term purpose.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give Clinical sciences the largest study block: its indicative allocation is 25 of 200 questions, spanning seven official subdivisions.
- Maintain regular pharmacology practice, especially molecular targets, delayed effects, monitoring and recognition of toxicity.
- For the eight domains allocated approximately 14 questions each, practise discriminating clinical patterns and interpreting investigations rather than memorising isolated labels.
- Use paired contrasts: symptom control versus stroke prevention, primary versus central adrenal failure, active versus latent tuberculosis, and filtration category versus CKD diagnosis.
- Rehearse urgent recognition of myasthenic respiratory weakness, retinal detachment, possible joint infection, endocarditis and tumour lysis.
- Include the smaller domains in every revision cycle; delirium, end-of-life comfort and bipolar episode classification require distinct reasoning.
- Learn numerical criteria together with their conditions: tumour lysis timing, post-bronchodilator obstruction, bipolar episode duration and CKD chronicity.
- Treat negative results as conditional evidence: examine exposure, IgA status, timing, disease duration and test sensitivity before excluding a diagnosis.
A practical preparation plan
1. Map the complete official scope
Create a study tracker using all 17 official domains and the seven Clinical sciences subdivisions. Use the indicative question allocations to distribute study time, then add topics beyond this selective guide from a comprehensive Part 1 curriculum.
2. Build mechanisms before associations
For each topic, explain the causal chain aloud: abnormal process, resulting symptom or laboratory pattern, and the decision it supports. Start with warfarin, neuromuscular transmission, hormonal feedback, iron balance, renal acid handling and hepatitis B markers.
3. Practise interpretation with units and timing
Calculate risk ratios and absolute effects, classify GFR and albuminuria using the correct units, and apply diagnostic thresholds with their timing requirements. Include recent central adrenal insufficiency, gluten exposure, IgA deficiency, lithium sampling and tumour lysis.
4. Complete and analyse the question drills
Answer the 20 questions before reading their explanations. For each error, identify whether the problem was missing knowledge, misreading a discriminating cue, calculation or an unjustified assumption. Explain why each competing option is weaker.
5. Space recall and expand weak areas
Use the flashcards for repeated active recall, then write a new mini-case for any uncertain answer. Expand weak domains using the full outline, and include best-of-five practice to become familiar with the official question style.
6. Integrate across specialties
Revisit cross-domain links: iron overload across organ systems, B12 deficiency across blood and nerves, autoimmune endocrine disease with coeliac testing, and anticancer treatment with metabolic emergencies. Keep urgent recognition separate from long-term classification and prevention.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Part 1: Format — The Federation
- Regulations — The Federation
- Regulations for MRCP(UK) Examination Candidates
- About us — The Federation
- Atrial fibrillation — NHS
- Warfarin sodium tablets — Prescribing information, DailyMed
- Principles of Epidemiology: Lesson 3, Section 6 — CDC
- Principles of Epidemiology: Lesson 3, Section 5 — CDC
- Psoriasis — NHS
- Diagnosis of Adrenal Insufficiency & Addison's Disease — NIDDK
- Coeliac disease: Diagnosis — NHS
- Delirium: Overview — Guy's and St Thomas' NHS Foundation Trust
- How to prevent delirium and help your recovery — Guy's and St Thomas' NHS Foundation Trust
- Vitamin B12–Deficiency Anemia — NHLBI
- Vitamin B12 or folate deficiency anaemia — NHS
- Clinical Testing and Diagnosis for Hepatitis B — CDC
- Myasthenia gravis — NHS
- Prevention of tumour lysis syndrome — eviQ, Cancer Institute NSW
- Retinal Detachment — National Eye Institute
- Changes in the last hours and days — NHS
- Bipolar Disorder — NIMH
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
- COPD: Diagnosis — NHS
- Gout — NHS
- Joint aspiration — Chelsea and Westminster Hospital NHS Foundation Trust
- Hereditary hemochromatosis — MedlinePlus Genetics
- Lithium monitoring — NHS Specialist Pharmacy Service
- Renal Tubular Acidosis — NIDDK
- Recommendations | Coeliac disease: recognition, assessment and management | Guidance | NICE
- Myasthenia gravis - Diagnosis - NHS
- Myasthenia Gravis – Overview | Research
- MeSH Browser
- full-guideline-pdf-4840895629
- Recommendations | Chronic obstructive pulmonary disease in over 16s: diagnosis and management | Guidance | NICE
- Endocarditis - NHS
- Tuberculosis (TB) - NHS
- Vitreous Detachment | National Eye Institute
- X-linked juvenile retinoschisis: MedlinePlus Genetics
- Psychiatry.org - What Are Bipolar Disorders?
- Recommendations | Gout: diagnosis and management | Guidance | NICE
- Recommendations | Atrial fibrillation: diagnosis and management | Guidance | NICE
- Recommendations | Care of dying adults in the last days of life | Guidance | NICE
- Characteristics of rapid cycling in 1261 bipolar disorder patients - PMC
- JBJI - Guideline for management of septic arthritis in native joints (SANJO)
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.